WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2010151565) COMBINATION THERAPIES FOR THE TREATMENT OF OBESITY
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2010/151565    International Application No.:    PCT/US2010/039588
Publication Date: 29.12.2010 International Filing Date: 23.06.2010
IPC:
A61K 31/13 (2006.01), A61K 31/135 (2006.01), A61K 31/155 (2006.01), A61K 9/20 (2006.01), A61K 9/48 (2006.01), A61P 3/04 (2006.01)
Applicants: METABOLOUS PHARMACEUTICALS, INC. [US/US]; c/o Third Rock Ventures 29 Newbury Street Boston, MA 02116 (US) (For All Designated States Except US).
ARONNE, Louis, J. [US/US]; (US) (For US Only)
Inventors: ARONNE, Louis, J.; (US)
Agent: GORDON, Dana, M.; Foley Hoag LLP Seaport World Trade Center 155 Seaport Blvd. Boston, MA 02210-2600 (US)
Priority Data:
61/220,730 26.06.2009 US
Title (EN) COMBINATION THERAPIES FOR THE TREATMENT OF OBESITY
(FR) MULTITHÉRAPIES POUR LE TRAITEMENT DE L'OBÉSITÉ
Abstract: front page image
(EN)Described are pharmaceutical compositions comprising sibutramine, metformin, and at least one pharmaceutically acceptable carrier or excipient. Another aspect of the present invention relates to a method of treating a patient suffering from obesity or needing to lose weight, comprising the step of co-administering to said patient a therapeutically effective amount of sibutramine and metformin. In certain embodiments, an aforementioned method is practiced in conjunction or tandem with a medical procedure or the use of a medical device or both.
(FR)L'invention concerne des compositions pharmaceutiques comprenant de la sibutramine, de la metformine, et au moins un support ou excipient pharmaceutiquement acceptable. Un autre aspect de la présente invention concerne un procédé de traitement d'un patient souffrant d'obésité ou devant perdre du poids, comprenant l'étape de co-administration audit patient d'une quantité thérapeutiquement efficace de sibutramine et de metformine. Dans certains modes de réalisation, un procédé susmentionné est appliqué conjointement à ou en tandem avec un protocole médical ou l'utilisation d'un dispositif médical ou les deux.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)